Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 6,660 out of 377,791 Researchers
Data For The Year: 2026
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 182,571 | 182,702 |
| Total Cites | 5,400 | 6,218 |
| H-index | 33 | 35 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 47 | 56 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1,436 | 1,580 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,049 | 3,367 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,314 | 3,676 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.69 |
| Self-Citation Percentage |
13.16%
|
|
Favaudon, Vincent
Signalisation Normale et Pathologique, de l'Embryon aux Therapies Innovantes des Cancers,
France
2025 Rank: 190,923
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 6,989 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 190,923 | 191,783 |
| Total Cites | 4,504 | 5,258 |
| H-index | 32 | 34 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 45 | 54 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1,126 | 1,255 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 2,553 | 2,849 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,854 | 3,187 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.65 |
| Self-Citation Percentage |
14.34%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.